CUSIP: 87164U102
Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
31,253,356
-
Share change
-
+37,905
-
Total reported value
-
$71,569,000
-
Price per share
-
$2.29
-
Number of holders
-
54
-
Value change
-
+$104,739
-
Number of buys
-
18
-
Number of sells
-
14
Quarterly Holders Quick Answers
What is CUSIP 87164U102?
CUSIP 87164U102 identifies SYN - SYNTHETIC BIOLOGICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2016
-
Previous quarter:
Q3 2015
Recent filing periods for CUSIP 87164U102:
Institutional Holders of SYNTHETIC BIOLOGICS INC - COM (SYN) as of Q4 2015
As of 31 Dec 2015,
SYNTHETIC BIOLOGICS INC - COM (SYN) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,253,356 shares.
The largest 10 holders included
Third Security, LLC, MSD Partners, L.P., Knoll Capital Management, LP, VANGUARD GROUP INC, BLAIR WILLIAM & CO/IL, BlackRock Institutional Trust Company, N.A., NORGES BANK, GEODE CAPITAL MANAGEMENT, LLC, Belmont Global Advisors, Inc., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
54
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.